Arthur Fratamico
Director/Board Member presso PANBELA THERAPEUTICS, INC.
Patrimonio netto: - $ in data 29/02/2024
Profilo
Arthur J.
Fratamico occupies the position of President & Chief Executive Officer for Radiant Biotherapeutics, Inc. He is also on the board of Panbela Therapeutics, Inc.
In his past career Mr. Fratamico occupied the position of Chief Business Officer at Galera Therapeutics, Inc., Chief Business Officer at Trevena, Inc., Vice President-Business Development & Licensing at MGI PHARMA, Inc., Chief Business Officer of Flexion Therapeutics, Inc., Chief Business Officer at Vitae Pharmaceuticals LLC, Chief Business Officer for Gemin X Pharmaceuticals US, Inc. and Principal at Hoechst Marion Roussel, Inc.
He received an MBA from Drexel University and an undergraduate degree from Philadelphia College of Pharmacy.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
PANBELA THERAPEUTICS INC
-.--% | 20/11/2023 | 0 ( -.--% ) | - $ | 29/02/2024 |
Posizioni attive di Arthur Fratamico
Società | Posizione | Inizio |
---|---|---|
PANBELA THERAPEUTICS, INC. | Director/Board Member | 16/12/2019 |
Radiant Biotherapeutics, Inc.
Radiant Biotherapeutics, Inc. BiotechnologyHealth Technology Radiant Biotherapeutics, Inc. develops multi-valent and specific bio therapeutics solutions. Arthur J. Fratamico has been the CEO of the Canadian company since 2021. | Chief Executive Officer | 01/05/2021 |
Precedenti posizioni note di Arthur Fratamico
Società | Posizione | Fine |
---|---|---|
GALERA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2021 |
VITAE PHARMACEUTICALS INC | Corporate Officer/Principal | 25/12/2016 |
FLEXION THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2014 |
TREVENA, INC. | Corporate Officer/Principal | - |
Hoechst Marion Roussel, Inc. | Corporate Officer/Principal | - |
Formazione di Arthur Fratamico
Drexel University | Masters Business Admin |
Philadelphia College of Pharmacy | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
GALERA THERAPEUTICS, INC. | Health Technology |
TREVENA, INC. | Health Technology |
PANBELA THERAPEUTICS, INC. | Health Technology |
Aziende private | 6 |
---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
Flexion Therapeutics, Inc.
Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Health Technology |
Hoechst Marion Roussel, Inc. | |
Radiant Biotherapeutics, Inc.
Radiant Biotherapeutics, Inc. BiotechnologyHealth Technology Radiant Biotherapeutics, Inc. develops multi-valent and specific bio therapeutics solutions. Arthur J. Fratamico has been the CEO of the Canadian company since 2021. | Health Technology |